Hong Kong SAR, China cLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China dHong Kong Institute of Diabetes and Obesity, The Chinese ...

Notably, GZR4 injection achieved superior HbA1c reduction in patients with inadequate glycemic control on prior basal insulin therapy compared to once-daily insulin degludec (Tresiba®).

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

Grab your cart quarter, and snag this diabetes-friendly Aldi snack. Choosing snacks with protein, fiber and healthy fats can ...

This stark disparity reflects deep-rooted challenges in American public health, particularly among people without higher ...

Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...

A new study links higher phytosterol intake to reduced risk of heart disease and diabetes. Diets rich in phytosterols were ...

No single food can reduce the risk of stroke; rather, eating a diet plentiful in fruits, vegetables, legumes, nuts, seeds, whole grains and lean protein is most important. But when it comes to ...

Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over ...

In a separate research note, Leerink Partners ... data are from a shorter trial in diabetes, the drug’s safety and efficacy appear comparable to Novo’s drug, Risinger wrote. Multiple analysts had a ...